Guidelines

PP32 Retrospective real-world data confirms the efficacy and safety of decitabine in treating patients with acute myeloid leukemia in Belgium

February 2017
PP33 Targeted next-generation sequencing using a pan-myeloid panel in myelodysplastic neoplasms: implementation in clinical diagnostics

February 2017
PP34 The MLL partial tandem duplication (MLL-PTD) is correlated with WT1 overexpression in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and shows a similar expression profile during treatment

February 2017
PP50 Comparison of xenogeneic graft-versus-host reactions in humanized NSG and NSG-HLA-A2/HHD mice

February 2017
PP51 Impact of Th17 cell population on xenogeneic graft-versus-host disease

February 2017
PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab

February 2017
PP53 Unexplained anaemia in the Elderly: High prevalence of functional iron deficiency and underdiagnosed myelodysplasia

February 2017
PP54 Diagnosis of de novo thrombotic microangiopathy after kidney transplantation

February 2017
PP55 Post-transfusion HbS monitoring on TOSOH G8 in variant HbA1c mode

February 2017
PP70 The use of adipose Stromal Vascular Fraction in a Platelet-Rich Fibrin scaffold within Bisphosphonate-Related Osteonecrosis of the Jaw treatment

February 2017

Top